サルメテロール

サルメテロール 化学構造式
89365-50-4
CAS番号.
89365-50-4
化学名:
サルメテロール
别名:
rac-(R*)-4-ヒドロキシ-3-ヒドロキシメチル-α-[[[6-(4-フェニルブトキシ)ヘキシル]アミノ]メチル]ベンゼンメタノール;サルメテロール;rac-2-(ヒドロキシメチル)-4-[(R*)-2-[[6-(4-フェニルブトキシ)ヘキシル]アミノ]-1-ヒドロキシエチル]フェノール;(±)-サルメテロール
英語名:
Salmeterol
英語别名:
CS-380;SN408D;gr33343x;GR 33343;SAMETEROL;Astmerole;SALMETEROL;BNKY006-SX05;Salmeterol base;Salmeterol, >=99%
CBNumber:
CB9186866
化学式:
C25H37NO4
分子量:
415.57
MOL File:
89365-50-4.mol

サルメテロール 物理性質

融点 :
75.5-76.5°
沸点 :
603.0±55.0 °C(Predicted)
比重(密度) :
1.112±0.06 g/cm3(Predicted)
貯蔵温度 :
2-8°C
溶解性:
クロロホルム(微量)、DMSO(微量)、メタノール(微量)
酸解離定数(Pka):
9.99±0.31(Predicted)
外見 :
個体
色:
ホワイトからオフホワイト
CAS データベース:
89365-50-4(CAS DataBase Reference)
安全性情報
  • リスクと安全性に関する声明
  • 危険有害性情報のコード(GHS)
RTECS 番号 CZ6457000
有毒物質データの 89365-50-4(Hazardous Substances Data)
絵表示(GHS) GHS hazard pictograms
注意喚起語 警告
危険有害性情報
コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード
H315 皮膚刺激 皮膚腐食性/刺激性 2 警告 GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 強い眼刺激 眼に対する重篤な損傷性/眼刺激 性 2A 警告 GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 呼吸器への刺激のおそれ 特定標的臓器毒性、単回暴露; 気道刺激性 3 警告 GHS hazard pictograms
注意書き
P261 粉じん/煙/ガス/ミスト/蒸気/スプレーの吸入を避ける こと。
P305+P351+P338 眼に入った場合:水で数分間注意深く洗うこと。次にコ ンタクトレンズを着用していて容易に外せる場合は外す こと。その後も洗浄を続けること。

サルメテロール 価格 もっと(3)

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入
富士フイルム和光純薬株式会社(wako) W01LKTS0245 サルメテロール
Salmeterol
89365-50-4 10mg ¥29400 2024-03-01 購入
富士フイルム和光純薬株式会社(wako) W01LKTS0245 サルメテロール
Salmeterol
89365-50-4 25mg ¥62700 2024-03-01 購入
富士フイルム和光純薬株式会社(wako) W01LKTS0245 サルメテロール
Salmeterol
89365-50-4 50mg ¥119100 2024-03-01 購入

サルメテロール 化学特性,用途語,生産方法

効能

気管支拡張薬, β2アドレナリン受容体作動薬

使用

Salmeterol is a β2-Adrenergic agonist used for relief and control of asthma symptoms.

定義

ChEBI: A phenol having a hydroxymethyl group at C-2 and a 1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl group at C-4; derivative of phenylethanolamine.

一般的な説明

Salmeterol has an N-phenylbutoxyhexyl substituent incombination with a β-OH group and a salicyl phenyl ring foroptimal direct-acting β2-receptor selectivity and potency. Ithas a potency similar to that of ISO. This drug associateswith the β2-receptor slowly resulting in slow onset of actionand dissociates from the receptor at an even slower rate. It is resistant to both MAO and COMT and highly lipophilic(log P=3.88). It is thus very long acting (12 hours), aneffect also attributed to the highly lipophilic phenylalkylsubstituent on the nitrogen atom, which is believed to interactwith a site outside but adjacent to the active site.
説明図

危険性

A poison by inhalation.

生物活性

Potent and selective β 2 -adrenoceptor agonist (EC 50 = 5.3 nM); bronchodilator. Unlike other β 2 agonists, binds to exo-site domain of β 2 receptors, producing a slow onset of action and prolonged activation. Also available as part of the β -Adrenoceptor Agonist Tocriset™ .

作用機序

A β2-agonist with a slow onset and extended duration of action is salmeterol. Salmeterol has the same phenyl ring substitution R3 as albuterol but also an unusually long and lipophilic group R1 on the nitrogen. The octanol–water partition coefficient, log P, for salmeterol is 3.88, compared with 0.66 for albuterol. Salmeterol is approximately 50-fold more selective than albuterol for the β2-receptor. Substantial evidence indicates that its long duration of action results from a specific binding interaction (“anchoring”) of the phenyl group at the end of the extended lipophilic side chain with a specific region of the β2-receptor, affording salmeterol a unique binding mechanism.

臨床応用

Salmeterol usually is prescribed for severe persistent asthma following previous treatment with a short-acting β-agonist, such as albuterol. The noticeable differences between salmeterol and albuterol are the onset of action and their duration of action (Table 13.6). When used regularly every day as prescribed, inhaled albuterol decreases the number and severity of asthma attacks. It is not used, however, for relieving an asthma attack that has already started.

副作用

Hoarseness, throat irritation, headache, rapid heartbeat, nervousness, cough, dry mouth/throat, or upset stomach may occur. To relieve dry mouth, suck on (sugarless) hard candy or ice chips, chew (sugarless) gum, drink water, or use a saliva substitute. This medication may raise your blood pressure. Rarely, this medication may cause sudden breathing problems/asthma right after you use it. If this occurs, use your quick-relief inhaler and get medical help right away.

代謝

Salmeterol is metabolized predominantly through CYP3A4, an isoform of cytochrome P450. CYP3A4 is responsible for the aliphatic oxidation of the salmeterol base. Salmeterol is extensively metabolized by hydroxylation into alpha-hydroxy-salmeterol and subsequently eliminated through feces and urine. Salmeterol is 57.4% eliminated in the feces and 23% in the urine. At recommended doses, systemic concentrations of salmeterol are low or undetectable. Only at very high doses are blood concentrations increased. 

サルメテロール 上流と下流の製品情報

原材料

準備製品


サルメテロール 生産企業

Global( 190)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
BIONNA MEDICINE CO.,LTD
01056380788-8515; +8618518759099
790226113@qq.com China 52 58
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8617865335152
Mandy@hangyubiotech.com China 11013 58
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512
info@tianfuchem.com China 21695 55
Hangzhou FandaChem Co.,Ltd.
008657128800458; +8615858145714
fandachem@gmail.com China 9350 55
Lianyungang happen teng technology co., LTD
15950718863
wang666xt@163.com CHINA 295 58
career henan chemical co
+86-0371-86658258
sales@coreychem.com China 29914 58
HubeiwidelychemicaltechnologyCo.,Ltd
18627774460
faith@widelychemical.com CHINA 742 58
Chongqing Chemdad Co., Ltd
+86-023-61398051 +8613650506873
sales@chemdad.com China 39916 58
Antai Fine Chemical Technology Co.,Limited
18503026267
info@antaichem.com CHINA 9641 58
WUHAN CIRCLE POWDER TECHNOLOGY CO.,LTD
+8615377521700
wangwendy93@gmail.com China 868 58

89365-50-4(サルメテロール)キーワード:


  • 89365-50-4
  • 4-HYDROXY-A1-[[[6-(4-PHENYLBUTOXY)HEXYL]AMINO]METHYL]-1,3-BENZENEDIMETHANOL
  • 2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino] ethyl]-phenol
  • SALMETEROL
  • (+-)-4-hydroxy-alpha1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedi
  • 1,3-benzenedimethanol,4-hydroxy-alpha1-(((6-(4-phenylbutoxy)hexyl)amino)methyl
  • gr33343x
  • SALMETEROL(SUBJECTTOPATENTFREE)
  • SAMETEROL
  • 1,3-Benzenedimethanol, 4-hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]- (9CI)
  • 1,3-Benzenedimethanol, 4-hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-, (+-)-
  • GR 33343, 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol
  • SalmeterolXenofoate
  • 4-Hydroxy-3-[hydroxymethyl]phenyl-N-[6-phenylbutoxyhexyl]ethanolamine
  • Salmeterol & Salmeterol Xinafoate
  • 4-Hydroxy-α1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol
  • 4-[(1R)-1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]aMino}ethyl]-2-(hydroxyMethyl)phenol
  • salmeterol Solution, 100ppm
  • GR 33343
  • Salmeterol, >=99%
  • BNKY006-SX05
  • CS-380
  • Astmerole
  • SN408D
  • [(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl]-[6-(4-phenylbutoxy)hexyl]ammonium
  • 1,3-Benzenedimethanol, 4-hydroxy-α1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-
  • Salmeterol USP/EP/BP
  • Salmeterol Xenofoate USP
  • (RS)-2-(hydroxymethyl)-4-{1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl}phenol (API)
  • Salmeterol base
  • rac-(R*)-4-ヒドロキシ-3-ヒドロキシメチル-α-[[[6-(4-フェニルブトキシ)ヘキシル]アミノ]メチル]ベンゼンメタノール
  • サルメテロール
  • rac-2-(ヒドロキシメチル)-4-[(R*)-2-[[6-(4-フェニルブトキシ)ヘキシル]アミノ]-1-ヒドロキシエチル]フェノール
  • (±)-サルメテロール
  • βアドレナリン作動薬
  • 抗喘息薬
  • 気管支拡張薬
Copyright 2017 © ChemicalBook. All rights reserved